Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient edoxaban, ATC B01AF03 for the period 01.04.2025 - 31.03.2026 (plus extension option 1 x 12 months) - 119768

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient edoxaban, ATC B01AF03 for the period 01.04.2025 - 31.03.2026 (plus extension option 1 x 12 months) - 119768 has been published on Bidding Source portal dated 27 Feb 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient edoxaban, ATC B01AF03 for the period 01.04.2025 - 31.03.2026 (plus extension option 1 x 12 months) - 119768

Tender Type :

Invitation for Bids

Country :

Germany

Publish Date :

27 Feb 2025

Closing Date :

5 Feb 2027

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – GWQ - Carglumic acid tender - 122212 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) for the active ingredient diclofenac (exclusively GEL 25 g), ATC D11AX18 for the period 01.04.2025 - 31.03.2027 - 121240 Germany Medicines containing the active ingredient filgotinib (ATC: L04AF04) - 110003 Germany Open House Original Discount Agreements 2025-08 - Roxadustat - 117106 Germany Pharmaceutical products – Open House discount contracts 2025-02 - 116293 Germany Medicines containing the active ingredient opipramol (ATC: N06AA05) - 111506 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.04.2025 to 31.03.2027 - 116854 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient Raltegravir 600 mg (ATC code according to WHO: J05AJ01) - 117896 Germany Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V with the active ingredient combination adapalene + benzoyl peroxide - 112942 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient Raltegravir 400 mg (ATC code according to WHO: J05AJ01) - 118694 Germany

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient edoxaban, ATC B01AF03 for the period 01.04.2025 - 31.03.2026 (plus extension option 1 x 12 months) - 119768

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com